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Abstract  Background/Objective:  The  heterogeneous  clinical  presentations  of  individuals  with
Autism Spectrum  Disorders  (ASD)  pose  a  signiﬁcant  challenge  for  sample  characterization.
Therefore  the  main  goal  of  DSM-5  must  be  to  identify  subgroups  of  ASD,  including  comorbidity
disorders  and  severity.  The  main  goal  of  this  study  is  to  explore  the  psychiatric  comorbidities
and the  severity  of  symptoms  that  could  be  relevant  for  the  phenotype  characterization  in  ASD
and also  to  compare  these  results  according  to  the  different  classiﬁcation  criteria  between
the DSM-IV-TR  and  the  DSM-5.  Method:  A  comparative  study  of  severity  and  psychiatric  comor-
bidities was  carried  out  between  a  sample  of  participants  that  only  met  criteria  for  Pervasive
Developmental  Disorder  (PDD)  according  to  the  DSM-IV-TR  and  a  sample  of  participants  that
also met  ASD  criteria  according  to  DSM-5  classiﬁcation.  The  recruitment  of  children  was  via
educational  (N  =  123).  The  psychiatric  symptoms,  comorbid  disorders  and  severity  of  symptoms
were assessed  through  The  Nisonger  Child  Behavior  Rating  Form,  clinical  interview  and  The
Inventory of  Autism  Spectrum  Disorder, respectively.  The  psychiatric  comorbidities  considered
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were:  anxiety,  eating  behavioural  problems,  self-aggressiveness,  hetero--aggressiveness,  self-
harm, obsessive  compulsive  disorder  and  attention  deﬁcit  and  hyperactivity  disorder.  Results:
Statistically  signiﬁcant  differences  between  both  groups  were  found  regarding  obsessive  com-
pulsive disorder,  eating  behavioural  problems  and  severity.  Conclusions:  The  results  support
the hypothesis  that  patients  who  meet  the  DSM-5  criteria  have  more  severe  symptoms,  not  only
regarding  the  core  autistic  symptoms  but  also  in  relation  with  psychiatric  comorbidities.
© 2016  Asociacio´n  Espan˜ola  de  Psicolog´ıa  Conductual.  Published  by  Elsevier  Espan˜a,  S.L.U.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Comorbilidades  psiquiátricas  en  los  trastornos  del  espectro  autista:  estudio
comparativo  entre  los  criterios  DSM-IV-TR  y  DSM-5
Resumen  Antecedentes/Objetivo:  Los  Trastornos  del  Espectro  Autista  (TEA)  incluyen  un  grupo
heterogéneo  en  cuanto  a  su  presentación  clínica,  que  supone  un  desafío  a  nivel  de  caracter-
ización diagnóstica.  Por  consiguiente,  el  objetivo  principal  de  la  clasiﬁcación  DSM-5  debería
de ser  identiﬁcar  subgrupos  de  TEA  incluyendo  severidad  y  comorbilidades  psiquiátricas.  El
objetivo principal  de  este  estudio  es  explorar  las  comorbilidades  diagnósticas  que  pueden  ser
relevantes  como  descriptores  de  fenotipos  autistas  así  como  la  severidad  de  los  síntomas  de
autismo y  comparar  los  resultados  de  las  diferentes  criterios  de  clasiﬁcación  entre  el  DSM-
IV-TR y  el  DSM-5.  Método:  Se  realiza  un  estudio  comparativo  de  severidad  y  comorbilidades
psiquiátricas  entre  una  muestra  con  diagnóstico  de  Trastorno  Generalizado  del  Desarrollo,
según criterios  DSM-IV-TR,  y  una  muestra  que  cumplía  también  criterios  para  TEA  según  la
clasiﬁcación  DSM-5.  La  muestra  fue  obtenida  en  centros  educativos  (N  =  123).  Las  comorbili-
dades psiquiátricas  y  la  severidad  de  los  síntomas  se  evaluaron  a  través  del  The  Nisonger  Child
Behavior Rating  Form,  entrevista  clínica  y  el  Inventario  de  Trastorno  del  Espectro  Autista,
respectivamente.  Las  comorbilidades  estudiadas  fueron  ansiedad,  alteraciones  de  la  conducta
alimentaria,  auto-agresividad,  hetero-agresividad,  autolesiones,  trastorno  obsesivo-compulsivo
y déﬁcit  de  atención  e  hiperactividad.  Resultados:  Se  encontraron  diferencias  estadística-
mente signiﬁcativas  entre  ambos  grupos  para  trastorno  obsesivo-compulsivo,  alteraciones  de
la conducta  alimentaria  y  severidad.  Conclusiones:  Se  apoya  la  hipótesis  de  que  los  individuos
que cumplen  criterios  diagnósticos  según  DSM-5  tienen  mayor  severidad  sintomática,  no  sólo
con respecto  a  los  síntomas  autistas  centrales,  sino  también  en  relación  con  comorbilidades
psiquiátricas.
© 2016  Asociacio´n  Espan˜ola  de  Psicolog´ıa  Conductual.  Publicado  por  Elsevier  Espan˜a,  S.L.U.
Este es  un  art´ıculo  Open  Access  bajo  la  CC  BY-NC-ND  licencia  (http://creativecommons.org/
licencias/by-nc-nd/4.0/).
Autism  Spectrum  Disorder  (ASD)  is  characterized  by
deﬁcits  in  social  interaction  and  communication,  as  well
as  the  presence  as  stereotyped  behaviour  and  restrictive
interests  (American  Psychiatric  Association,  APA,  2013).  In
the  past,  all  psychiatric  problems  in  children  and  adults
with  autism  used  to  be  attributed  to  autism  itself.  However,
an  increasing  number  of  studies  are  arguing  for  accepting
behaviours  and  symptoms  that  had  been  considered  addi-
tional  or  associated  features  of  ASD  as  potentially  indicating
the  presence  of  comorbidities  warranting  additional  diag-
nosis.  Individuals  diagnosed  with  ASD  often  present  other
psychiatric  disorders,  such  as  attention  deﬁcit  and  hyperac-
tivity  disorder  (ADHD),  anxiety  disorders,  mood  alterations,
etc.  (Simonoff  et  al.,  2008).  It  has  been  suggested  that
comorbidity  will  generally  lead  to  more  severe  impairments
as  a  result  of  the  cumulative  effects  of  having  more  than  one
disorder  (Gadow,  Guttmann-Steinmetz,  Rieffe,  &  Devincent,
2012).  Autism  is  generally  a  lifelong  condition  beginning
in  childhood  and  with  pathological  outcomes  in  adulthood.
Outcomes  are  often  described  as  difﬁculties  or  issues  in
ﬁnance,  employment  and  socialization  (Fountain,  Winter,  &
Bearman,  2012). When  other  problematic  symptoms  are  rec-
ognized  as  manifestation  of  comorbid  psychiatric  disorders,
rather  than  just  isolated  symptoms,  more  speciﬁc  treat-
ment  is  possible.  For  this  reason,  comorbidity  identiﬁcation
should  include  those  symptoms  which  are  sufﬁcient  for  a
comorbidity  diagnosis  and  those  isolated  symptoms  which
can  be  relevant  as  descriptors  of  individual  phenotypes  such
as  eating  behaviour  problems,  behaviour  difﬁculties  such  as
self-aggression  or  hetero-aggression.
One  of  the  goals  of  the  new  classiﬁcation  (DSM-5)  must
be  to  identify  subgroups  of  ASD,  including  comorbidity  disor-
ders,  which  may  be  important  to  understand  the  biological
mechanisms,  the  clinical  results  and  the  reactions  of  the
individuals  with  ASD  to  the  treatment.  It  has  been  proposed
a  phenotypic  characterization  to  improve  the  classiﬁcation
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of  ASD  based  not  only  on  the  speciﬁc  items  of  ASD,  but
involving  other  speciﬁc  characterizations  such  as  cognitive
and  adaptive  function,  language  skills,  comorbidity,  other
medical  conditions  and  other  psychiatric  features  in  order
to  standardize  the  clinical  characteristics  of  individuals  with
ASD  (Grzadzinski,  Huerta,  &  Lord,  2013).
The  publication  of  the  ﬁfth  edition  of  the  DSM  has  inten-
siﬁed  a  debate  since  the  announcement  of  the  changes
in  diagnostic  criteria  proposed  by  the  APA.  There  is  an
increment  of  studies  that  open  many  questions  about
the  diagnostic  validity  of  the  DSM-5  (Robles  et  al.,  2014;
Rodríguez-Testal,  Senín-Calderón,  &  Perona-Garcelán,  2014;
Timimi,  2014).  One  of  the  important  controversies  is  the
diagnosis  of  ASD.  The  DSM-5  uniﬁes  the  ﬁrst  and  the  sec-
ond  domain  into  a  single  category  which  include  meeting
all  three  distinctions  of  Social  Communication  and  Interac-
tion  (SCI).  The  DSM-5  classiﬁcation  assembles  the  Pervasive
Developmental  Disorders  (PDD)  with  different  diagnostic
subtypes  into  a  single  dimensional  category  of  ASD,  grouped
by  severity  levels  (McPartland,  Reichow,  &  Volkmar,  2012;
Worley  &  Matson,  2012).  There  is  an  accord  in  different
articles,  stating  that  the  new  classiﬁcation  requires  more
severe  symptomatology  for  the  diagnosis  (Gibbs,  Aldridge,
Chandler,  Witzlsperger,  &  Smith,  2012;  Matson,  Kozlowski,
Hattier,  Horovitz,  &  Sipes,  2012;  Turygin,  Matson,  Beighley,
&  Adams,  2013).
The  DSM-5,  with  difference  to  DSM-IV-TR,  admits  comor-
bidity  with  Attention  Deﬁcit  and  Hyperactivity  Disorders
(ADHD)  in  patients  diagnosed  with  ASD.  Many  studies  showed
a  high  percentage  of  children  diagnosed  with  ASD,  who
require  health  services,  have  ADHD  comorbidity  (Brereton,
Tonge,  &  Einfeld,  2006;  Holtmann,  Bolte,  &  Poustka,  2007;
Sinzig,  Walter,  &  Doepfner,  2009;  Yerys,  Wallace,  Jankowski,
Bollich,  &  Kenworthy,  2011).  Also,  estimates  of  impairing
anxiety  range  from  11--84%  in  school-aged  children  with  ASD
and  as  many  as  40%  meet  criteria  for  an  anxiety  disorder
(Kerns  &  Kendall,  2013;  van  Steensel,  Bogels,  &  Perrin,  2011;
White,  Oswald,  Ollendick,  &  Scahill,  2009).  These  reviews
note  a  wide  range  of  estimates  attributable  to  differences
in  the  sample  source,  sample  size  and  assessment  methods
employed.  These  rates  of  anxiety  disorders  in  youth  with
ASD  are  nearly  two-fold  higher  than  current  estimates  in
typically  developing  children  (Costello,  2005).  Other  reports
indicate  that  Separation  Anxiety  and  Generalized  Anxiety
(Gadow,  DeVincent,  Pomeroy,  &  Azizian,  2004)  also  occur  at
higher  than  expected  rates  in  youth  with  ASD.  Although  the
majority  of  previous  studies  involved  clinic-based  samples,
community-based  studies  also  indicate  that  children  with
ASD  are  at  greater  risk  of  anxiety  (Simonoff  et  al.,  2008).
Because  of  pure  phenomenological  reasons,  the  Obses-
sive  Compulsive  Disorders  (OCD)  and  autism  include  the
behavioural  appearances  (e.g.,  the  compulsions  in  the  OCD;
rituals  and  routines  in  ASD)  and  cognitive  appearances  (the
obsession  in  the  OCD;  equality  insistence  and  worries  in
ASD).  Although  the  form  and  content  of  these  symptoms  are
different  in  both  disorders  (McDougle  et  al.,  1995;  Zandt,
Prior,  &  Kyrios,  2007);  autism  tends  to  involve  less  complex
forms  which  are  perhaps  due  to  the  existence  of  cogni-
tive  disorders  and/or  language.  Despite  of  any  overlap,  the
proﬁle  of  repetitive  behaviours  in  autism  and  OCD  is  also  dif-
ferentiable  (Bejerot,  2007).  For  example,  individuals  with
OCD  usually  do  not  have  repetitive  motor  behaviours  often
associated  with  autism  (e.g.,  hand  ﬂapping).  In  addition,
individuals  with  OCD  exhibit  more  cleaning,  checking  and
counting  behaviours,  while  individuals  with  autism  engage
in  more  hoarding,  ordering,  touching/tapping,  and  self-
inﬂicted  injuries  (McDougle  et  al.,  1995).  The  underlying
causes  of  repetitive  behaviour  are  unclear,  although  the
modulation  of  arousal  is  usually  suggested  for  ASD,  and  anx-
iety  for  OCD  (Zandt  et  al.,  2007).
In  addition,  children  with  early  symptoms  of  neuropsy-
chiatric  disorders  present  a  higher  frequency  of  behavioural
eating  problems  (Bandini  et  al.,  2010)  compared  with
children  who  do  not  have  any  disorders  (Bryant-Waugh,
Markham,  Kreipe,  &  Walsh,  2010).  Some  published  studies  of
children  diagnosed  with  ASD,  show  an  estimated  90%  preva-
lence  of  eating  problems  (Kodak  &  Piazza,  2008).  According
to  another  study,  the  prevalence  of  eating  problems  was
0.6%  in  the  control  study  population  and,  among  children
with  eating  problems,  40%  were  screened  positive  for  ADHD
and/or  ASD  (Rastam  et  al.,  2013).  Similarly,  self-harm,  self-
injurious  behaviours  and  hetero-aggression  are  very  common
in  children  diagnosed  with  Pervasive  Developmental  Disor-
der  (PDD).  In  fact,  the  drugs  used  in  ASD  are  aimed  at
treating  behavioural  and  symptomatic  problems,  despite
these  symptoms  are  not  part  of  the  core  symptoms  of  ASD
(Soutollo,  2010).  For  this  reason,  the  characterization  of  ASD
should  consider  the  assessment,  not  only  of  the  comorbid
disorders  but  also,  the  independent  symptoms  that  might
inﬂuence  on  the  functionality  or  on  the  medical  treatment
of  this  population.
Therefore,  the  main  goal  of  the  present  study  was  to  ana-
lyse  the  clinical  diagnostic  comorbidities  and  the  isolated
psychiatric  symptoms  which  can  be  relevant  as  descriptors
of  autistic’s  phenotype.  A  comparative  study  was  carried  out
between  a  sample  of  patients  with  PDD  diagnosis  accord-
ing  to  the  DSM-IV-TR  criteria  and  a  sample  of  patients  with
clinical  diagnosis  of  ASD  according  to  DSM-5.  It  is  hypothe-
sized  that  the  group  of  patients  who  met  the  DSM-5  criteria
have  more  severe  symptomatology,  not  only  regarding  the
severity  of  core  autistic  symptoms  but  also  in  relation  with
different  comorbid  conditions.
Method
Participants
The  recruitment  of  patients  was  via  educational  institutions
in  Málaga  (Southern  Spain).  According  to  the  census  of  indi-
viduals  between  5  and  15  years  registered  in  the  province
of  Malaga  and  data  from  the  Spanish  National  Institute
of  Statistics,  the  number  of  individuals  enrolled  in  school
was  56,839.  The  study  was  conducted  accordingly  with  the
Helsinski  Declaration  and  was  approved  by  the  Local  Com-
munity  Ethics  Committee.  See  ﬂow  diagram  in  Figure  2.
Individual  and  parents’  interviews  were  made  in  the  Unit
of  Child  and  Adolescents  Mental  Health  in  Carlos  Haya  Hos-
pital  in  Malaga  (Southern  Spain),  after  signing  the  informed
consent.  Psychiatrists  and  psychologists  with  experience
in  children  and  adolescents  carried  out  the  assessments.
Firstly,  it  was  conﬁrmed  the  community  diagnosis  for  PDD  by
the  clinical  interview  and  according  to  the  checklist  DSM-IV-
TR/ICD-10  scale.  In  term  of  demographic  features;  the  mean
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Figure  1  Proposed  Diagnostic  and  Statistical  Manual  of  Mental  Disorders,  5th edition  (DSM-5)  criteria  and  associated  features  to
be considered  when  characterizing  autism  spectrum  disorder  (ASM)  samples  (Grzadzinski  et  al.,  2013,  with  permission).
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Figure  2  Flow  diagram.
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age  of  participants  was  10.62  and  82%  of  the  sample  were
males.
Instruments  and  Procedure
In  order  to  conﬁrm  the  clinical  diagnosis  of  PDD,  the
DSM-IV-TR/ICD-10  Checklists  were  selected.  Psychometric
properties  of  the  DSM-IV-TR/ICD-10  Checklist  have  been
shown  to  be  satisfactory  as  inter-rater  reliability  (r  =  .89),
test-retest  reliability  (r  =  .97),  and  internal  consistency
(  =  .95)  were  all  robust  (Gonzalez,  2008;  Matson,  Dempsey,
Lovullo,  &  Wilkins,  2008;  Worley  &  Matson,  2012).  The  DSM-5
clinical  diagnosis  for  ASD  was  assessed  by  child  psychiatrists
according  to  the  DSM-5  manual,  published  in  May,  2013.  As
we  can  see  in  the  Figure  1,  and  consistently  with  the  DSM-5,
patients  should  have  meet  the  three  items  of  the  criteria
A,  belonging  to  the  domain  of  sociability  and  at  least  two
items  for  the  criteria  B,  restrictive  interest  and/or  repetitive
behaviour  domain  (RRB).  The  DSM-IV-TR/ICD-10  checklist
scale  was  also  used  for  this  purpose.  Finally,  the  total  sam-
ple  of  patients  diagnosed  with  PDD  according  to  DSM-IV-TR
was  divided  into  two  groups:  (1)  DSM-5  group;  individuals
who  met  also  the  DSM-5  criteria  for  ASD  and  (2)  Non  DSM-5
group;  individuals  who  only  met  DSM-IV-TR  criteria  for  PDD
(not  DSM-5  criteria).
Variables  of  psychiatric  comorbidities  were  obtained
by  the  clinical  assessment,  and  parents’  interviews,  using
the  DSM-IV-TR  criteria.  The  comorbid  conditions  studied
were:  (1)  Attention  Deﬁcit  and  Hyperactivity  Disorder  and
(2)  Obsessive  Compulsive  Disorder.  Moreover,  the  following
independent  psychiatric  symptoms  were  assessed  the  same
way:  (1)  Anxious  or  too  fearful,  (2)  Physically  harms  or  hurts
self  on  purpose,  (3)  Physically  attacks  people,  (4)  Self-harm
enough  to  leave  tooth  marks  or  break  skin  and  (5)  Eating
behavioural  problems.
The  prevalence  and  frequency  of  some  of  these  symptoms
(1,  2,  3),  were  collected  according  to  The  Nisonger  Child
Behaviour  Rating  Form  (NCBRF)  (Problem  behaviour  sub-
scale)  (Aman,  Burrow,  &  Wolford,  1995).  The  NCBRF  (Norris
&  Lecavalier,  2011)  is  a  factor-analytically  derived  scale
with  items  rated  from;  did  not  occur  or  was  no  a  problem
(0)  to  behaviour  occurred  a  lot  or  was  a  severe  problem
(3).  There  are  two  versions  of  the  NCBRF:  a  parent  and
teacher  version.  The  Conduct  subscale  of  the  NCBRF  has
been  used  as  an  outcome  measure  in  placebo  controlled  tri-
als  of  children  with  mild  developmental  disabilities  (Brown,
Aman,  &  Havercamp,  2002;  Snyder  et  al.,  2002).  It  has  also
been  used  to  characterize  a  large  sample  of  children  with
ASD  (Lecavalier,  2006).  Concerning  the  item  of  (4)  self-harm
enough  to  leave  tooth  marks  or  break  skin,  the  symptom
was  collected  through  the  clinical  history  of  the  emergency
visits  or  medical  specialist  consultation  due  to  this  cause
(YES/NO).
Finally,  the  information  about  eating  behaviour  problems
was  collected  during  the  clinical  interview  with  the  parents.
It  was  codiﬁed  according  to  the  frequency  of  appearance,
similar  to  the  NCBRF  scale;  from  did  not  occur  or  was  no
a  problem  (0)  to  behaviour  occurred  a  lot  or  was  a  severe
problem  (3).
Severity  of  symptomatology  was  assessed  by  Autism
Spectrum  Disorder  Inventory  (IDEA)  (Rivière,  2002).  It  is
an  inventory  that  includes  12  dimensions  of  development,
divided  into  4  areas  (Social  development,  language  and
communication,  anticipation  and  ﬂexibility,  symbolizing).
Each  dimension  is  scored  from  0  (no  qualitative  disorder)
to  8  (maximum  involvement  level)  at  intervals  of  2  (0,  2,  4,
6,  8),  being  able  to  use  odd  scores  when  considering  that
the  symptomatology  is  at  an  intermediate  point  between  2
consecutive  items.  The  inventory  was  built  with  the  aim  of
assess  the  severity  of  the  core  features  of  ASD.
Statistical  analysis
Statistical  analysis  was  performed  using  SPSSTM 21.0  with
1000  samples  bootstrapping.  After  checking  the  linear  model
assumptions  (Kolmogorov--Smirnov  and  Shapiro--Wilk  tests)
dimensional  variables  and  frequencies  were  compared  by
parametric  or  non-parametric  tests  as  appropriate  (Chi
Square  Test  and  Student  t-test).  The  bivariate  association
between  the  two  groups  (DSM-5  vs.  Non  DSM-5)  and  inde-
pendent  variables  (comorbid  disorders,  other  psychiatric
symptoms  and  severity  of  symptoms)  was  initially  explored
using  either  two-way  cross-tabulations  or  mean  compar-
isons.  We  assumed  a  signiﬁcance  level  of  p  ≤  .05.
Results
Clinical  and  sociodemographic  distribution
The  Table  1  shows  the  distribution  of  the  number  of  patients
who  met  DSM-5  criteria  (DSM-5  group)  and  patients  who  did
not  (Non  DSM-5)  and  the  prevalence  of  the  different  Autism
Spectrum  Disorders  (ASD)  subgroups  according  to  the  DSM-IV
TR  [Autistic  Disorder,  Asperger’s  and  pervasive  developmen-
tal  disorder-not  otherwise  speciﬁed  (PDD-NOS)].  There  were
no  signiﬁcant  differences  between  both  groups  in  relation
with  the  distribution  of  ASD  subtypes  (2 =  0.99;  p  =  .61).
Also,  no  signiﬁcant  differences  in  age  was  found  between
both  groups  (t-Student  =  -0.47;  p  =  .64)  (mean  age:  10.62;
SD:  2.99).  The  82%  of  the  sample  were  males  and  the  eth-
nicity  of  the  sample  was  100%  Caucasian.
Comorbidity  with  Attention  Deﬁcit  Hyperactivity
Disorder  (ADHD)
The  Table  1  illustrates  the  distribution  of  the  number  of  par-
ticipants  who  had  clinical  comorbidity  with  ADHD.  Statistical
analysis  showed  a  non-signiﬁcance  value  (2 =  3.48;  p  =  .06),
although  it  had  a  tendency  toward  the  signiﬁcance,  as  there
was  a  higher  percentage  of  participants  with  comorbidities
in  the  DSM-5  group.
Comorbidity  with  Obsessive  Compulsive  Disorder
(OCD)
As  it  can  be  seen  in  the  Table  1,  statistically  signiﬁcant  dif-
ferences  between  both  groups  were  observed  (2 =  18.96;
p  =  .0001).  In  conclusion,  patients  fulﬁlling  the  DSM-5  crite-
ria  for  ASD  had  higher  prevalence  of  OCD  diagnosis.
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Table  1  Distribution  of  the  number  of  patients  who  met  DSM-5  criteria  (DSM-5  group)  and  patients  who  did  not  (Non  DSM-5)
showing the  prevalence  of  the  different  Autism  Spectrum  Disorders  (ASD)  subgroups  and  comorbidity  with  Attention  Deﬁcit
Hyperactivity Disorder  (ADHD),  Obsessive  Compulsive  Disorder  (OCD),  Anxiety,  Eating  behavior  problems,  Auto-aggression,
Hetero-aggression  and  Self-harm.  Statistical  differences  between  both  groups  are  described.
No  DSM-5
Count  (%)
DSM-5
Count  (%)
Total
Count  (%)
p
ASD  subtypes Autism  17  (25.8%)  17  (29.8%)  34  (27.6%) .61
Asperger  13  (19.7%)  14  (24.6%)  27  (22%)
PDD-NOS  36  (54.5%)  26  (45.6%)  62  (50.4%)
Total 66  (100%)  57  (100%)  123  (100%)
ADHD No 33  (50%)  19  (33.3%)  52  (42.3%) .06
Yes 33  (50%)  38  (66.7%)  71  (57.7%)
Total 66  (100%)  57  (100%)  123  (100%)
OCD No 51  (77.3%)  22  (38.6%)  73  (59.3%) .0001
Yes 15  (22.7%)  35  (61.4%)  50  (40.7%)
Total 66  (100%)  57  (100%)  123  (100%)
Anxiety No occur  6  (9.5%)  4  (7%)  10  (8.3%) .09
Occasional  39  (61.9%)  24  (42.1%)  63  (52.5%)
Quite often  4  (6.3%)  5  (8.8%)  9  (7.5%)
Severe  problem  14  (22.2%)  24  (42.1%)  38  (31.7%)
Eating behaviour
problems
No  occur  33  (52.4%)  16  (28.6%)  49  (41.2%) .05
Occasional  12  (19%)  17  (30.4%)  29  (24.4%)
Quite often  4  (6.3%)  3  (5.4%)  7  (5.9%)
Severe  problem  14  (22.2%)  20  (35.7%)  34  (28.6%)
Auto-aggression No occur  42  (66.7%)  31  (54.4%)  73  (60.8%) .57
Occasional  5  (7.9%)  6  (10.5%)  11  (9.2%)
Quite often  4  (6.3%)  6  (10.5%)  10  (8.3%)
Severe  problem  12  (19%)  14  (24.6%)  26  (21.7%)
Hetero-aggression No occur  40  (64.5%)  31  (56.4%)  71  (60.7%) .31
Occasional  12  (19.4%)  12  (21.8%)  24  (20.5%)
Quite often 1  (1.6%)  5  (9.1%)  6  (5.1%)
Severe  problem  9  (14.5%)  7  (12.7%)  16  (13.7%)
Self-harm No 54  (81.8%)  41  (71.9%)  95  (77.2%) .20
Yes 12  (18.2%) 16  (28.1%)  28  (22.8%)
Total 66  (100%) 57  (100%) 123  (100%)
Anxiety  or  too  fearful
Assessing  the  frequency  of  symptoms  of  anxiety  or  too  fear
between  both  groups,  it  was  observed  a  tendency  of  hav-
ing  more  severe  problems  in  the  group  of  participants  who
met  DSM-5  criteria  (63%),  although  there  were  no  statisti-
cally  signiﬁcant  differences  between  both  groups  (2 =  6.43;
p  =  .09).  See  Table  1.
Eating  behaviour  problems
The  Table  1  shows  the  distribution  and  the  frequency  of
participants  who  presented  eating  behaviour  problems.  Sta-
tistically  signiﬁcant  differences  were  found  between  both
groups  in  relation  with  this  symptom  (2 =  7.57;  p  =  .05).
A  higher  prevalence  of  eating  behaviour  problems  was
observed  in  participants  who  met  the  criteria  for  ASD
according  to  the  DSM-  5.
Auto-aggression,  hetero-aggression,  self-harm
Comorbidities  with  auto-aggression,  hetero-aggression  and
self-harm,  are  shown  in  Table  1, respectively.  When  both
groups  were  compared,  not  signiﬁcant  differences  were
found  (2 =  2.01;  p  =  .57),  (2 =  3.65;  p  =  .31)  and  (2 =  1.70;
p  = .20),  respectively.
Severity  of  Autism  Spectrum  Disorder
In  order  to  assess  the  severity  of  the  core  autistic  symptoms,
The  Autism  Spectrum  Inventory  (IDEA)  was  used  (Table  2).
The  null  hypothesis  of  equal  variances  (Levene’s  test),  was
rejected  and  it  was  concluded  that  there  was  a  signiﬁcant
difference  between  the  variances  of  these  measures.  Con-
sequently,  the  statistical  analysis  Kolmogorov-Smirnov  was
used  and  it  showed  that  the  group  of  patients  who  met  DSM-
5  criteria  had  more  severe  symptoms  than  the  Non  DSM-5
group  with  statistical  signiﬁcant  differences  (p  =  .0001).
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Table  2  Comparative  study  between  No  Autism  Spectrum
Disorders  (ASD)  DSM-5  and  ASD  DSM  5  group  for  severity  of
autistic  symptoms.  Mean  (SD)  [CI  95].
Total
Sample
(n  =  120)
No-ASD
DSM-5
(n  =  63)
ASD  DSM-5
(n  =  57)
p
IDEA  43(8.82)
[41.41  to
44.59]
38,86  (8.69)
[36.67  to
41.04]
47,58  (6.41)
[45.88  to
49.28]
.0001
Discussion
Based  on  the  data  presented  in  this  study,  there  is
no  question  that  comorbid  symptomatology  are  quite
prevalent  in  children  with  ASD.  Variables  such  as  spe-
ciﬁc  behavioural  symptoms,  ADHD,  OCD  and  severity  of
symptoms,  likely  have  an  inﬂuence  on  the  autism  indi-
vidual’s  experience.  The  present  study  shows  that  the
new  classiﬁcation  DSM-5  requires  more  severe  symptoma-
tology  for  the  diagnosis  of  ASD  and  also,  the  group  of
patients  who  met  the  DSM-5  criteria  for  ASD,  are  more
likely  to  develop  psychiatric  comorbidities,  speciﬁcally
OCD  and  eating  problems.  Previous  studies  have  supported
the  hypothesis  of  the  DSM-5  could  signiﬁcantly  improve
the  speciﬁcity  at  the  expense  of  loss  sensitivity  in  ASD
(APA,  2013;  Frazier  et  al.,  2012;  Grzadzinski  et  al.,  2013;
Wing,  Gould,  &  Gillberg,  2011).  However,  to  the  best  of
our  knowledge,  no  previous  studies  have  compared  both
classiﬁcations  in  term  of  severity  and  comorbidities  in
this  population.  Therefore,  this  study  suggests  that  DSM-5
classiﬁcation  has  been  able  to  identify  children  with  the
most  severe  symptomology;  however,  it  might  fail  to  identify
those  with  high  functioning  autism  or  less  severe  sympto-
matology.  Consequently,  in  term  of  clinical  implication,  the
DSM-5  criteria  could  have  a  high  impact  in  the  diagnosis  of
ASD.  Authors  of  the  present  study  also  support  the  proposal
of  a  phenotypic  characterization,  to  improve  the  DSM-5  clas-
siﬁcation  for  ASD.
Methodology  issues  and  further  research
By  addressing  methodological  issues  that  limit  the  ﬁndings
of  this  study,  future  studies  can  contribute  noticeably  to  our
better  understanding  about  the  impact  of  the  new  classiﬁ-
cation  in  this  population  and  answer  more  pointed  scientiﬁc
questions  in  relation  with  the  phenotypic  characterization.
The  present  study  did  not  employ  any  independent  ‘gold
standard’  conﬁrmation  for  the  ASD  diagnoses  [i.e.,  Autism
Diagnostic  Interview-Revised  (ADI-R);  (Lord,  Rutter,  &  Le
Couteur,  1994)  or  Autism  Diagnostic  Observation  Schedule
(ADOS)  Lord  et  al.,  2000)];  instead,  including  children  based
on  community  and  clinical  diagnosis  with  the  DSM-IV-TR/ICD-
10  Checklists  conﬁrmation.
This  study  was  also  limited  by  the  fact  that  the  diagnosis
of  ASD  according  to  DSM-5  was  completed  using  the  items  of
DSM-IV-TR/ICD-10  Checklists.  Although  this  method  has  been
also  used  previously  in  other  studies  (Beighley  et  al.,  2013;
Matson,  Hattier,  &  Williams,  2012),  new  objective  measures
will  need  to  be  developed  in  order  to  accurately  capture  the
patients  who  meet  ASD  criteria  according  to  DSM-5  classiﬁ-
cation  if  valid  and  reliable  measures  cannot  be  identiﬁed  at
the  current  time.
In  relation  with  the  assessment  for  comorbid  psychi-
atric  symptoms  such  as  eating  disorders,  anxiety,  auto-and
hetero-aggressiveness  and  self-arm,  research  on  the  appli-
cability  of  traditional  measures  of  childhood  psychiatric
symptoms,  is  sorely  needed.  Until  we  have  consensus  on
‘best  practice’  measures,  a  healthy  skepticism  is  called  for
with  respect  to  the  precision  of  the  tools  we  currently  have
for  measuring  symptoms  of  comorbid  problems  in  children
with  ASD.  Assessment  of  global  severity  is  another  important
consideration  in  treatment  outcome  research;  yet,  there  is
little  guidance  on  its  evidence-based  assessment  for  children
with  ASD  (White,  Smith,  &  Schry,  2014).
One  of  the  main  strength  of  the  methodology  in  this  study
was  in  relation  with  the  representativeness  of  the  sample
of  participants.  The  present  study  drew  their  ASD  sample
from  a  large  population-derived,  non-clinical  patients.  Clin-
ical  samples  are  often  needed  to  accrue  an  adequate  number
of  participants  and  for  ensuring  statistical  power,  but  such
samples  can  make  it  difﬁcult  to  generalize  ﬁndings.  Clinic-
based  samples  are  likely  not  representative  of  all  children
with  ASD  in  many  important  respects,  such  as  degree  of
parental  investment,  level  of  behaviour  disturbance,  etc.
Main  results
The  ﬁndings  of  the  current  study  support  the  overall  a  priori
hypothesis.  It  was  found  that  participants  who  met  DSM-5
criteria  had  higher  prevalence  of  clinical  comorbidities  and
severity.  According  to  the  analysis  of  comorbidity  with  atten-
tion  deﬁcit  disorder  and  hyperactivity  (ADHD),  the  results
showed  that  there  were  no  statistical  signiﬁcant  differences
between  both  groups.  However,  there  is  a  tendency  toward
higher  prevalence  in  the  DSM-5  group.  The  absence  of  a  sta-
tistical  signiﬁcance  could  be  due  the  sample  size  of  patients
with  comorbid  ADHD  (n  =  71).  According  to  the  last  review,
the  prevalence  has  been  remarkably  heterogeneous,  ran-
ging  from  4%  to  94%  (weighted  mean  prevalence  =  48%;  Frias,
Palma,  &  Farriols,  2015).  For  example,  Rao  and  Landa  (2014)
obtained  a  lower  percentage  of  29%  as  it  focused  on  a  non-
clinical  recruitment  to  avoid  over  diagnosis.  Congruently,
the  current  study  was  focused  on  non-clinical  participants
and  we  found  a  prevalence  of  57.7%.  These  ﬁndings  support
the  hypothesis  that  the  comorbidity  with  ADHD  may  consti-
tute  a  distinctive  phenotype  of  ASD,  and  these  children  may
be  at  a greater  risk  of  involvement  and  socially  adaptive
problems.  Moreover,  ADHD  is  a  condition  that  produces  high
academic  dysfunctionality  and  therefore,  exacerbates  the
academic  and  social  needs  of  children  who  present  comor-
bidity  with  ASD.  This  is  important  because  participants  with
both  conditions  are  given  various  treatments  or  strength
requirements  than  those  which  have  only  ASD.  These  results
are  congruent  with  a  growing  number  of  studies  that  have
shown  that  both  pathologies  can  co-exist  (Rao  &  Landa,
2014).
In  the  present  study  the  results  have  showed  that  par-
ticipants  meeting  DSM-5  criteria  for  ASD  have  more  OCD
comorbidity.  The  ASD  diagnosis  according  to  DSM-5  requires
greater  rigidity  in  the  behavioural  domain,  unlike  in  the
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DSM-IV-TR.  One  of  the  most  signiﬁcant  changes  in  the  DSM-5
classiﬁcation  is  the  higher  requirement  in  the  area  of  repet-
itive  and  restrictive  behaviour,  requiring  two  of  the  four
items  compared  to  the  DSM-IV-TR  criteria  where  only  one
item  was  required  for  the  diagnosis  of  PDD  (Howlin,  Goode,
Hutton,  &  Rutter,  2004;  Mattila  et  al.,  2011).  For  that  rea-
son,  the  similarities  that  exist  between  routines  and  rituals
behaviour  in  ASD  and  compulsions  in  OCD;  obsession  in  the
OCD  and  equality  insistence  and  worries  in  ASD,  indicate
that  clinicians  should  make  the  assessment  very  carefully
in  order  to  make  a  correct  differential  diagnosis.  If  the
assessment  is  only  focused  on  the  DSM-5  criteria,  the  comor-
bid  diagnosis  of  OCD  might  be  imprecise  in  individuals  with
ASD.  Therefore,  exploration  into  the  overlapping  and  dis-
tinct  phenotypic  presentations  of  individuals  with  comorbid
presentations  (e.g.,  ASD  with  OCD)  versus  presentations  of
OCD  or  ASD  singly  may  be  of  potential  importance  for  under-
standing  the  biological  markers  of  these  disorders.  Further
genetic  and  neuro-imaging  studies  are  needed  in  order  to
better  understand  this  approach.
In  addition,  the  present  study  found  signiﬁcant  differ-
ences  with  eating  behaviour  problems  between  both  groups,
supporting  the  hypothesis  of  having  more  comorbidity  in  the
DSM-5  group.  Previous  published  studies  of  children  diag-
nosed  with  ASD  showed  an  estimated  eating  problem  which
reaches  90%  of  prevalence  (Kodak  &  Piazza,  2008).  However,
in  this  study  we  obtained  a  lower  percentage  between  28.6%
and  51%  because  we  focused  on  a  non-clinical  recruitment
to  avoid  over  diagnosis.
Even  without  a  clinical  diagnosis,  the  results  found  that
31.7%  of  patients  had  severe  problems  with  anxiety,  congru-
ent  with  the  review  of  van  Steensel,  Bogels,  and  Perrin
(2011),  in  which  a  percentage  of  40%  was  found.  Anxiety  is
an  important  factor  in  the  daily  lives  of  many  children  and
adolescents  with  ASD  diagnosis.  Children  and  adolescents
with  ASD  generally  take  longer  to  communicate  their  symp-
toms  of  anxiety  due  to  their  communication  problems,  many
of  which  only  manifest  themselves  internally  (i.e.,  constant
worry).  These  limitations  make  it  difﬁcult  for  people  with
ASD  to  be  diagnosed  because  of  the  difﬁculties  to  express
their  own  feelings  or  problems.  Unfortunately,  there  is  lit-
tle  clarity  on  how  best  to  assess  other  psychiatric  comorbid
symptoms  in  this  population  and  the  direct  impact  on  the
ASD  severity.
Finally,  these  ﬁndings  do  support  the  proposal  of
Grzadzinski  et  al.  (2013),  in  order  to  highlight  the  impor-
tance  of  carrying  out  a  phenotypic  characterization  to
improve  the  DSM-5  classiﬁcation,  based  not  only  on  the  spe-
ciﬁc  core  symptoms  of  ASD  but  also  in  their  comorbidities
and  other  factors  that  may  inﬂuence  on  the  functionality  of
this  complex  spectrum  of  autism  (Fig.  1).
Conclusions
This  study  supports  the  hypothesis  that  the  DSM-5  classi-
ﬁcation  includes  patients  who  are  more  prone  to  clinical
severity  not  only  in  relation  to  the  core  items  of  ASD,  but
also  at  the  level  of  psychiatric  comorbidities.  Patients  who
met  DSM-5  criteria  had  more  comorbidity  with  OCD,  eat-
ing  behaviour  problems  and  severity  than  patients  who  only
met  the  DSM-IV-TR  criteria.  Future  studies  can  contribute
markedly  to  our  better  understanding  the  effect  of  the  new
classiﬁcation  in  this  population  and  answer  more  pointed
scientiﬁc  questions  in  relation  with  the  phenotypic  catego-
rization  of  children  with  autism  spectrum  disorder.
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